Figure 1.
Distribution of participants with severe HA by CFC exposure and reason for study exit. Of 171 patients, 164 (95.9%) had CFC exposure at some time during the study; 113 of 164 (68.9%) had CFC exposure through prophylaxis, including 7 who also had FVIII mimetic prophylaxis; and 51 of 164 (31.1%) only had on-demand CFC exposure, including 7 who also had FVIII mimetic prophylaxis. Of 171 patients, 7 (4.1%) had no CFC exposure. In addition, of 113 patients who were on CFC prophylaxis, 85 exited because of 50 EDs (2 also were prescribed an FVIII mimetic); 22 exited because of FVIII inhibitor (none were also prescribed an FVIII mimetic); and 6 exited because of study closure (5 were also prescribed an FVIII mimetic).

Distribution of participants with severe HA by CFC exposure and reason for study exit. Of 171 patients, 164 (95.9%) had CFC exposure at some time during the study; 113 of 164 (68.9%) had CFC exposure through prophylaxis, including 7 who also had FVIII mimetic prophylaxis; and 51 of 164 (31.1%) only had on-demand CFC exposure, including 7 who also had FVIII mimetic prophylaxis. Of 171 patients, 7 (4.1%) had no CFC exposure. In addition, of 113 patients who were on CFC prophylaxis, 85 exited because of 50 EDs (2 also were prescribed an FVIII mimetic); 22 exited because of FVIII inhibitor (none were also prescribed an FVIII mimetic); and 6 exited because of study closure (5 were also prescribed an FVIII mimetic).

or Create an Account

Close Modal
Close Modal